Girentuximab Biosimilar: Targeting Carbonic Anhydrase IX (CAIX) for Cancer Therapy Girentuximab is a monoclonal antibody targeting carbonic anhydrase IX (CAIX), a tumor- … read more 10th Dec 2024 Shanza Riaz
Tesnatilimab Biosimilar: Advancing CD38-Targeted Therapy Tesnatilimab is a monoclonal antibody targeting CD38, a transmembrane glycoprotein hig … read more 10th Dec 2024 Shanza Riaz
Etigilimab Biosimilar: Advancing TIGIT Inhibition in Cancer Immunotherapy Etigilimab is a monoclonal antibody targeting TIGIT (T-cell immunoglobulin and ITIM do … read more 10th Dec 2024 Shanza Riaz
